Krishna Institute of Medical Sciences Limited (KIMS) has announced that its Board will meet on 11 March 2026 to evaluate fundraising options. The proposal includes issuing equity shares through Qualified Institutions Placements (QIP), rights issue, or other permissible modes, subject to shareholder and regulatory approvals.
Krishna Institute of Medical Sciences Limited has formally notified the stock exchanges about a scheduled Board meeting on 11 March 2026. The agenda centers on exploring fundraising avenues to strengthen the company’s financial position and support future growth.
Key Highlights
-
The Board will deliberate on raising funds through equity issuance in one or more tranches
-
Options under consideration include Qualified Institutions Placements (QIP), rights issue, or a combination of permissible modes
-
The proposal will be subject to approvals from shareholders, regulators, and statutory authorities
-
Issue price determination will be finalized by the Board at its discretion
-
A shareholders’ meeting may be convened to seek formal approval for the fundraising plan
This move signals KIMS’s intent to bolster its capital base, potentially enabling expansion and strategic investments in healthcare infrastructure. Investors and stakeholders will closely watch the outcome of the Board’s decision, as it could shape the company’s financial trajectory in the coming quarters.
Source: Krishna Institute of Medical Sciences Limited filing with Stock Exchanges